Medical supplies contracts in Germany

299 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Abiraterone (exclusively 500 mg 90 units), ATC L02BX03, for the period 01.12.2025 – 30.11.2027

DAK-Gesundheit, HamburgTED 685930-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

341days

Contrast media - Cross-sector open-house procedure for the KV region Westfalen-Lippe

AOK NordWest, HagenTED 779421-2025

€13 lots, 2 years

Sun 31 Oct12:00 in Berlin

367days

Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Lebrikizumab, ATC code D11AH10 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 764802-2025

€11 lot, 2 years

Mon 1 Nov12:00 in Berlin

368days

Conclusion of a non-exclusive discount agreement under § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Tildrakizumab, ATC L04AC17, for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 762347-2025

€11 lot, 2 years

Mon 1 Nov12:00 in Berlin

368days

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V (Open-House model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 342032-2026

value not stated5 lots

Mon 1 Nov12:00 in Berlin

368days

Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Dimethyl fumarate, ATC code D05BX02 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 762620-2025

€11 lot, 2 years

Mon 1 Nov12:00 in Berlin

368days

Open-House Contracts 2025-4

AOK Bremen/BremerhavenTED 730881-2025

value not stated1 lot

Thu 4 Nov12:00 in Berlin

371days

Open-House Contracts 2025-5 - Aflibercept

AOK Bremen/BremerhavenTED 766959-2025

value not stated1 lot

Thu 4 Nov23:59 in Berlin

371days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Formoterol + Beclometasone (exclusively Dafo. IHP, INH), ATC R03AK08 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 778063-2025

€11 lot, 2 years

Fri 5 Nov12:00 in Berlin

372days

Conclusion of a non-exclusive rebate agreement pursuant to § 130a Abs. 8 SGB V for the active substance Peginterferon beta-1a, ATC L03AB13 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 762539-2025

€11 lot, 2 years

Fri 5 Nov12:00 in Berlin

372days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Buserelin, ATC L02AE01 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 763308-2025

€11 lot, 2 years

Fri 5 Nov12:00 in Berlin

372days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substances Insulin lispro, ATC A10AB04 and A10AD04 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 764522-2025

€11 lot, 2 years

Fri 5 Nov12:00 in Berlin

372days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Paliperidone (exclusively 3-month depot), ATC N05AX13 for the period 01.01.2026 - 31.12.2027

DAK-Gesundheit, HamburgTED 762978-2025

€11 lot, 2 years

Fri 5 Nov12:00 in Berlin

372days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Teriparatid, ATC H05AA02 for the period 01.02.2026 - 31.01.2027 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 831213-2025

€11 lot, 1 year

Sun 5 Dec12:00 in Berlin

402days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Pasireotide, ATC H01CB05 for the period 01.02.2026 - 31.01.2028

DAK-Gesundheit, HamburgTED 832580-2025

€11 lot, 2 years

Sun 5 Dec12:00 in Berlin

402days

Conclusion of a non-exclusive discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Follitropin, ATC code G03GA05 for the period from 01.02.2026 to 31.01.2028

DAK-Gesundheit, HamburgTED 829368-2025

€11 lot, 2 years

Sun 5 Dec12:00 in Berlin

402days

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 186318-2026

value not stated9 lots

Sat 1 Jan12:00 in Berlin

429days

Open-House Contracts 2026-1

AOK Bremen/BremerhavenTED 696053-2026

value not stated44 lots

Wed 5 Jan23:59 in Berlin

433days

Conclusion of agreements for the economic supply of finished medicinal products for outpatient care within an Open House model

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 72816-2026

value not stated31 lots

Tue 1 Feb12:00 in Berlin

460days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ciclesonid, ATC R03BA08, for the period 01.04.2026 – 31.03.2027 (plus extension option of 1x12 months)

DAK-Gesundheit, HamburgTED 111527-2026

€11 lot, 1 year

Sat 5 Feb12:00 in Berlin

464days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.